๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Adebrelimab

SCRT VS LCRT Followed by PD-L1 Inhibitor Plus CAPEOX as TNT in Patients With LARC NCT07284992Phase 21 site๐Ÿ“ Jinan Shandong Provincial Hospital ยท Tests: short-term radiotherapy combined with Adebrelimab and capox, long-term radiotherapy combined with Adebrelimab and capox Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC NCT06467617Phase 21 site๐Ÿ“ Beijing Beijing Chest Hospital, Capital Medical University ยท Tests: Adebrelimab plus albumin-bound paclitaxel, carboplatin and recaticimab A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC NCT06925516Phase 21 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: Apatinib and Adebrelimab in Combination With chemotherapy A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies NCT06181032Phase 11 site๐Ÿ“ Fuzhou First Affiliated Hospital of Fujian Medical University ยท Tests: Adebrelimab, Apatinib, Gemcitabine, Cisplatin Second-line Immunotherapy for ES-SCLC NCT06853678NA1 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Adebrelimab, Selinexor, Nab-paclitaxel Adebrelimab + Apatinib in SCLC Maintenance Therapy NCT06475209Phase 21 site๐Ÿ“ Xi'an Tang-Du Hospital ยท Tests: Adebrelimab combined with Apatinib GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma NCT06455410Phase 212 sites๐Ÿ“ Foshan๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: GP, Adebrelimab, concurrent chemoradiotherapy (CCRT) A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer NCT07110571Phase 22 sites๐Ÿ“ Shijiazhuang๐Ÿ“ Hangzhou Suzhou Suncadia Biopharmaceuticals Co., Ltd. ยท Tests: Adebrelimab Injection, SHR-A1811 for Injection, SHR-A1904 for Injection, SHR-8068 Injection Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ NCT06808971Phase 21 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Adebrelimab, Nab-paclitaxel, Oxaliplatin, Tegafur Gimeracil Oteracil Potassium Capsule A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy NCT07559786Phase 22 sites๐Ÿ“ Zhengzhou๐Ÿ“ Zhengzhou Henan Cancer Hospital ยท Tests: CCRT(Employed residual field irradiation(RFI)), CCRT(Involved-Field Radiotherapy (IFRT)) Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer. NCT05753826Phase 21 site๐Ÿ“ Fujian Fujian Cancer Hospital ยท Tests: Adebrelimab, Fuzuloparib Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors๏ผšA Prospective Exploratory Study NCT07542002Phase 21 site๐Ÿ“ Ningbo Ningbo Medical Center Lihuili Hospital ยท Tests: Irinotecan liposome, 5-fluorouracil/leucovorin, and oxaliplatin, with or without adadelimab. Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma NCT06091124Phase 25 sites๐Ÿ“ Nanjing๐Ÿ“ Xi'an๐Ÿ“ Shanghai RenJi Hospital ยท Tests: Adebrelimab, Etoposide, Cisplatin, Radical Cystectomy A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer NCT06512051Phase 1, Phase 21 site๐Ÿ“ Beijing Shanghai Hengrui Pharmaceutical Co., Ltd. ยท Tests: SHR-A2102 for Injection, Adebrelimab Injection, Cisplatin injection, Carboplatin injection, Bevacizumab Injection Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer NCT07353684Phase 21 site๐Ÿ“ Beijing Beijing Friendship Hospital ยท Tests: Adebrelimab, Apatinib, SOX Chemotherapy Adebrelimab ยฑInduction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC NCT06510660Phase 21 site๐Ÿ“ Fuzhou Fujian Medical University Union Hospital ยท Tests: adebrelimab Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer NCT07718490Phase 22 sites๐Ÿ“ Nanjing๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Adebrelimab Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC NCT06500208Phase 21 site๐Ÿ“ Shanghai Shanghai Jiao Tong University School of Medicine ยท Tests: Adebrelimab combined with nab-paclitaxel, epirubicin and cyclophosphamide A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma NCT06869213Phase 21 site๐Ÿ“ Beijing Peking University Cancer Hospital & Institute ยท Tests: Adebrelimab (SHR-1316) + Nab-paclitaxel + Cisplatin Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib in Advanced HER2-Positive/Low-Expression Biliary Tract Cancer NCT07704177Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Trastuzumab Rezetecan, Adebrelimab, Lenvatinib Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer NCT06433609Phase 21 site๐Ÿ“ Beijing Beijing GoBroad Hospital ยท Tests: SHR-A1811, SHR-A1921, Adebrelimab, SHR-A2102 Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) NCT07241793Phase 26 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Adebrelimab, Trastuzumab Rezetecan The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma NCT06266832Phase 21 site๐Ÿ“ Hangzhou Sir Run Run Shaw Hospital ยท Tests: Adebrelimab, Oxaliplatin, Capecitabine, Short-course Radiation, Biopsy Adebrelimab and Chemoradiotherapy in High-risk LANPC NCT06349889Phase 24 sites๐Ÿ“ Xiamen๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Adebrelimab Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma NCT07595770Phase 21 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: โ€ข Adebrelimab and nab-paclitaxel, carboplatin in Combination With radiotherapy Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer NCT07522151Phase 31 site๐Ÿ“ Beijing Shanghai Shengdi Pharmaceutical Co., Ltd ยท Tests: Adebrelimab plus S-1 and oxaliplatin, Adebrelimab blank preparation plus S-1 and oxaliplatin. Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer NCT06280508Phase 21 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: Adebrelimab, Apatinib, Gemcitabine, cisplatin Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer NCT07170995Phase 31 site๐Ÿ“ Jinan Suzhou Suncadia Biopharmaceuticals Co., Ltd. ยท Tests: SHR-8068๏ผŒadebelizumab and platinum-based chemotherapy, tislelizumab, and platinum-based chemotherapy Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer NCT06149130Phase 21 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Adebrelimab, dalpiciclib Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer NCT06765616Phase 21 site๐Ÿ“ Jinan Feng Tian ยท Tests: Adebrelimab Injection combined with radiotherapy and chemotherapy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy